Saltar al contenido

Max Wolff

@trpwolff.bsky.social did:plc:m2b7df5p4dq5c3sxb4ppmc54

Psychologist, psychotherapist and clinician-researcher with research focus on psychedelic therapy Humboldt-Universität zu Berlin

En Bluesky desde el

Seguidores
1.546
Siguiendo
278
Posts
270
Días en rankings
0

Resumen

Max Wolff (@trpwolff.bsky.social) es un usuario de Bluesky que se unió el 14 octubre 2023. Tiene 1.546 seguidores, sigue a 278 cuentas y ha publicado 270 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • Manoj Doss not exist@manojdoss.bsky.social

    We got a new review/model on why we think psychedelics might be particularly useful in the treatment of anxiety-related disorders. link.springer.com/article/10.1... Good work @htmcgovern.bsky.social on carrying this through the finish line.

    Ver post
  • Hugh McGovern PhD@htmcgovern.bsky.social

    Being a psychedelic enthusiast accounts for a huge amount of how psychedelics increase quality of life. In other words, the drug is not the territory. Will publish on this issue soon.

    Ver post
  • Rich Haridy@richharidy.bsky.social

    New data drop from Definium's phase 3 LSD for anxiety trial. This one is most interesting for its dose response data. Only the second dose response phase 3 read out after Compass. Here are the two readouts. Compass comparing 10mg of psilocybin against 25mg and Definium comparing 50mcg LSD to 100.

    Ver post
  • Hugh McGovern PhD@htmcgovern.bsky.social

    New single just dropped. link.springer.com/article/10.1...

    Ver post
  • Manoj Doss not exist@manojdoss.bsky.social

    New paper on the phenomenology of heightened familiarity under psychedelics! www.tandfonline.com/doi/full/10....

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.